Lonza | LONN - Current Liabilities

Stock Price
481.00
Daily Change
-3.50 -0.72%
Monthly
-8.76%
Yearly
-12.29%
Q1 Forecast
468.93

Lonza reported CHF3.58B in Current Liabilities for its fiscal semester ending in December of 2024.





Current Liabilities Change Date
Akzo Nobel EUR 4.21B 631M Dec/2025
Alcon AG USD 3.05B 59M Dec/2025
Almirall EUR 350.64M 52.12M Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
BASF EUR 16.41B 838M Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
Beiersdorf EUR 3.51B 261M Dec/2025
Covestro EUR 3.87B 299M Dec/2025
Demant DKK 7.42B 1.63B Dec/2025
Fresenius EUR 9.56B 1.27B Sep/2025
Fresenius Medical Care EUR 6.25B 485.68M Dec/2025
Geberit CHF 854.7M 192.6M Dec/2024
Genmab DKK 629M 127M Jun/2025
Givaudan CHF 2.97B 911M Jun/2024
GlaxoSmithKline GBP 21.39B 57M Dec/2025
GN Store Nord DKK 7.32B 153M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Johnson Matthey GBP 2.32B 155M Dec/2025
Merck EUR 9.04B 405M Dec/2025
Novartis USD 32B 286M Sep/2025
Philips EUR 7.51B 479M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
Sika AG CHF 2.8B 211.8M Jun/2025
Smith & Nephew USD 1.54B 236M Dec/2025
Solvay EUR 1.85B 287M Dec/2025
UCB EUR 3.53B 731M Dec/2024